EA
Empery Asset Management, LP cut its ANVS stake below 5%
Empery Asset Management, LP reported owning 5% of Annovis Bio, Inc. (ANVS) (2,241,537 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.